Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Department of Epidemiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, People's Republic of China.
J Thorac Cardiovasc Surg. 2019 Dec;158(6):1559-1570.e2. doi: 10.1016/j.jtcvs.2019.01.129. Epub 2019 Feb 23.
Because of an increased risk of sternal wound complications, the use of bilateral internal thoracic artery grafting in diabetic patients remains controversial. The objective of the present meta-analysis is to compare the safety and efficacy of single internal thoracic artery and bilateral internal thoracic artery grafting in the diabetic population.
Four electronic databases, including PubMed, the Cochrane Library, Embase, and ISI Web of Knowledge, were comprehensively searched. Prospective randomized trials or observational studies comparing single internal thoracic artery and bilateral internal thoracic artery were considered eligible for the current study.
A literature search yielded 1 randomized controlled trial and 17 observational studies (129,871 diabetic patients: 124,233 single internal thoracic arteries and 5638 bilateral internal thoracic arteries). Pooled analysis demonstrated overall incidence of deep sternal wound infection in the bilateral internal thoracic artery grafting group was significantly higher than in the single internal thoracic artery grafting group (3.26% for bilateral internal thoracic artery vs 1.70% for single internal thoracic artery). No significant difference was found between both groups in terms of risk of deep sternal wound infection when the skeletonized harvesting technique was adopted. Furthermore, in-hospital mortality was comparable between both groups (2.80% for bilateral internal thoracic artery vs 2.36% for single internal thoracic artery). However, compared with single internal thoracic artery grafting, bilateral internal thoracic artery grafting could confer a lower risk for long-term overall mortality (hazard ratio, 1.41; 95% confidence interval, 1.18-1.67; P < .001; I = 63%) and cardiac mortality (hazard ratio, 3.15; 95% confidence interval, 2.23-4.46; P < .001; I = 0%).
Compared with single internal thoracic artery grafting, bilateral internal thoracic artery grafting is associated with enhanced long-term survival among diabetic patients. Skeletonization of bilateral internal thoracic artery is not associated with an increased risk of deep sternal wound infection. Therefore, surgeons should be encouraged to adopt bilateral internal thoracic artery grafting in a skeletonized manner more routinely in diabetic patients.
由于胸骨伤口并发症的风险增加,糖尿病患者使用双侧内乳动脉移植仍然存在争议。本荟萃分析的目的是比较糖尿病患者中单支内乳动脉和双侧内乳动脉移植的安全性和疗效。
全面检索了 4 个电子数据库,包括 PubMed、Cochrane 图书馆、Embase 和 ISI Web of Knowledge。纳入比较单支内乳动脉和双侧内乳动脉的前瞻性随机试验或观察性研究。
文献检索得到 1 项随机对照试验和 17 项观察性研究(129871 例糖尿病患者:124233 例单支内乳动脉和 5638 例双侧内乳动脉)。汇总分析显示,双侧内乳动脉移植组的深部胸骨伤口感染总发生率明显高于单支内乳动脉移植组(双侧内乳动脉 3.26%,单支内乳动脉 1.70%)。采用游离皮瓣技术时,两组深部胸骨伤口感染的风险无显著差异。此外,两组的住院死亡率相当(双侧内乳动脉 2.80%,单支内乳动脉 2.36%)。然而,与单支内乳动脉移植相比,双侧内乳动脉移植可降低长期全因死亡率的风险(风险比 1.41;95%置信区间 1.18-1.67;P<0.001;I=63%)和心源性死亡率(风险比 3.15;95%置信区间 2.23-4.46;P<0.001;I=0%)。
与单支内乳动脉移植相比,双侧内乳动脉移植可提高糖尿病患者的长期生存率。双侧内乳动脉游离皮瓣并不增加深部胸骨伤口感染的风险。因此,应鼓励外科医生更常规地采用双侧内乳动脉游离皮瓣技术。